Cargando…
Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539925/ https://www.ncbi.nlm.nih.gov/pubmed/37769401 http://dx.doi.org/10.1016/j.esmoop.2023.101832 |
| _version_ | 1785113609260498944 |
|---|---|
| author | Grinda, T. Pistilli, B. |
| author_facet | Grinda, T. Pistilli, B. |
| author_sort | Grinda, T. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10539925 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Elsevier |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105399252023-09-30 Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? Grinda, T. Pistilli, B. ESMO Open Editorial Elsevier 2023-09-26 /pmc/articles/PMC10539925/ /pubmed/37769401 http://dx.doi.org/10.1016/j.esmoop.2023.101832 Text en © 2023 The Author(s) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
| spellingShingle | Editorial Grinda, T. Pistilli, B. Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? |
| title | Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? |
| title_full | Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? |
| title_fullStr | Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? |
| title_full_unstemmed | Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? |
| title_short | Are ERBB2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? |
| title_sort | are erbb2 mutations a ‘ready for routine use’ target in patients with metastatic breast cancer? |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10539925/ https://www.ncbi.nlm.nih.gov/pubmed/37769401 http://dx.doi.org/10.1016/j.esmoop.2023.101832 |
| work_keys_str_mv | AT grindat areerbb2mutationsareadyforroutineusetargetinpatientswithmetastaticbreastcancer AT pistillib areerbb2mutationsareadyforroutineusetargetinpatientswithmetastaticbreastcancer |